Department of Health and Human Services' logo Department of Health and Human Services

Public Health Service
Food and Drug Administration
Florida District Office

 

7200 Lake Ellenor Dr #120
Orlando, FL 32809
Telephone: 407-648-6823

January 14, 1998
WARNING LETTER
VIA CERTIFIED MAIL, RETURN RECEIPT REQUESTED

Johnny L. Johnson, Owner & CEO
The Aloe Man, Inc.
18800 NW 2nd Ave #102-110
Miami, FL 33169

Ref. No. FLA-98-18

Dear Dr Johnson:

During an inspection of your firm on August 20, 22, and 27, 1997, FDA Investigator Jennifer M. Donzanti found that your firm is manufacturing and marketing various products which are labeled and promoted for conditions which cause them to be drugs according to [Section 201(g) of the Federal Food, Drug, and Cosmetic Act (the Act)]. We regard your promotional literature as labeling, since i.t makes therapeutic claims for the products.

Aloe Man products are considered drugs because claims made for them establish their intended use as a drug. Each of the listed products is followed by some examples of the drug claims found in the product labeling.

The Master Healer:
sugar diabetes, asthma, ulcers, broken bones, bronchitis, dissolves blood clots, valvular heart disease, varicose veins, cancer (slows or stops growth), powerful diuretic (congested heart failure [sic]), lupus, bladder and kidney disease, pneumonia, high blood pressure, Immune builder — helps ailment as AIDS, HIV and other immune problems.
The Body Healer:
diarrhea, dysentery, prolapsus of the uterus or anus, gonorrhea, prostatic enlargement, hernia, bleeding from lungs or stomach, aid in the elimination of venereal warts, helps stop bleeding cancer, ulcers, reduces or shrinks tumors.
Super Bright:
cataract, glaucoma, nearsightedness, farsightedness, detached retina, macular degeneration, blood behind the eyes.
Special Tea #232:
fibroid tumors, cyst in breast, Endometriosis, pelvic infection.
Diasulin:
diabetes
Olé Arthur:
partial paralysis, rheumatoid, bursitis, swelling, gout.
Maximum Desire:
impotence
Pros-Guard:
prostate enlargement, swelling of prostate urinary problems.
The Big "C":
fight circulating cancer cells, fight tumor growth, boils, ulcers, sores, warts, cysts, hard cancers, ringworms, blood clots, (sic) psoriasis, prostate problems, gangrene.
Formula C:
relief of leg cramps, Rejuvenates kidneys, help kidney problems, help bladder problems, help urine problems, frequent urine, unable to control urine, slow urine, pancreas.
G.A.P:
high blood pressure, diabetes and arthritis.

Further, we have no information that your products are generally recognized as safe and effective for the above referenced conditions and may not be legally marketed in the US without approval of a new drug application [Section 505(b) of the Act].

These drugs are also misbranded [Section 502(a) of the Act] because their labeling is false and misleading and suggests that there is evidence that the drugs are safe and effective when this is not the case. These drugs are also misbranded [Section 502(f)(1) of the Act] because their labeling fails to bear adequate directions for use [Section 502(f)(1) of the Act].

Furthermore, drugs manufactured or repacked by your firm are also misbranded according to Section 502(o) of the Act since they are manufactured in a facility that is not registered with the FDA, as required by the Drug Registration and Listing Act (Section 510 of the Act), nor has the proper listing information been filed (21 CFR, Section 207).

Drug products manufactured by your firm, including Dr Johnson's Body Healer, Master Healer, and Big "C" are also adulterated within the meaning of Section 501(a)(2)(B) of the Act in that they are drugs and the methods used in, and the facilities and controls used for, their manufacture, processing, packing or holding do not conform to or are not administered in conformity with current good manufacturing practice (GMP) regulations as specified in 21 CFR, Part 211, as follows:

No component, in-process or finished product testing; no stability testing, nor is there an expiration date on the label; no reserve samples; no label controls; no master records and incomplete batch records; no written procedures for component handling, production and process control, prevention or control of microbiological contamination, the distribution of drug products, or cleaning/maintenance of equipment; no quality control unit and no written procedures describing the responsibilities and functions of such a unit; and, personnel lack the necessary training to adequately perform their duties.

This letter is not intended to be an all inclusive review of all labeling and products your firm markets. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations.

We request that you take prompt action to correct these violations. Failure to promptly correct violations may result in enforcement action being initiated by the Food and Drug Administration without further notice. The Federal Food, Drug, and Cosmetic Act provides for seizure of illegal products and for injunction against the manufacturer and/or distributor of illegal products.

Please notify this office in writing within 15 working days of receipt of this letter as to the specific steps you have taken to correct the stated violations. You should also include an explanation of each step being taken to identify and make corrections to assure that similar violations will not recur. If corrective action cannot be completed within 15 working days, state the reason for the delay and the time within which the corrections will be implemented.

Your reply should be sent to the Food and Drug Administration, Florida District, 7200 Lake Ellenor Dr #120, Orlando, FL 32809, Attention: Martin E. Katz, Compliance Officer, telephone 407-648-6823, extension 262.

Sincerely,
/s/
Edward R. Atkins
Acting District Director

This page was posted on August 20, 2006.

Links to Recommended Companies